ReviewFrontiers in immunology2026
Clinical complete response to serplulimab plus bevacizumab and chemotherapy in MSS/KRAS-mutant metastatic sigmoid colon adenocarcinoma: a case report and literature review.
Qiao Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.